Great outlook for venture investments in biotech start-ups

Biotech-teknoWith Life Science Tennessee’s annual conference starting September 28, we thought this was an insightful article. It notes that the outlook for venture capital investment in biotechnology start-ups has never been better since the tracking of such data started two decades ago. To register for the conference, click here.

Tom Ballard

By Tom Ballard, Chief Alliance Officer,
Pershing Yoakley & Associates. P.C.

eNews & Updates

Sign up to receive posts via email.

Connect With Us

Upcoming Events

Links to Partners